The renin-angiotensin-aldosterone system in pre-eclampsia

被引:101
作者
Brown, MA
Wang, JA
Whitworth, JA
机构
[1] ST GEORGE HOSP,DEPT MED,KOGARAH,NSW 2217,AUSTRALIA
[2] ST GEORGE HOSP,DEPT OBSTET,KOGARAH,NSW 2217,AUSTRALIA
[3] UNIV NEW S WALES,KOGARAH,NSW 2217,AUSTRALIA
关键词
renin; aldosterone; angiotensin; angiotensinogen; pregnancy; hypertension; pre-eclampsia;
D O I
10.3109/10641969709083181
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Pre-eclampsia is characterised physiologically by plasma volume contraction, intravascular coagulation and intense vasoconstriction. It was originally thought that the renin-angiotensin-aldosterone (RAA) system would be overactive but studies have shown a more complex picture. Plasma renin activity (PRA) and concentration (PRC) and plasma angiotensin II (AII) and aldosterone concentrations (PAC) are reduced compared to normal pregnancy. Total renin concentration is normal and plasma concentrations of high molecular weight angiotensinogen are increased in pre-eclampsia though total angiotensinogen is normal. PRA and PRC respond appropriately to physiologic stimuli in pre-eclampsia except for impaired renin release following frusemide, possibly due to prostacyclin deficiency. Although plasma AII concentrations are reduced there is heightened presser sensitivity to infused AII - the mechanism(s) for this are unknown. PAC is reduced but the ratio PAC:PRC is twofold greater in pre-eclampsia than normal pregnancy. This does not appear to be due to changes in potassium, atrial natriuretic peptide, dopamine or ACTH, and may be another manifestation of increased (adrenal) sensitivity to AII in pre-eclampsia. There is an inverse relationship between the plasma active renin to prorenin ratio and the clinical severity of pre-eclampsia. Understanding the mechanisms producing these changes in the RAA system in pre-eclampsia will give strong clues to the overall pathogenesis of this disorder.
引用
收藏
页码:713 / 726
页数:14
相关论文
共 46 条
[31]  
Itskovitz J, 1987, Obstet Gynecol Surv, V42, P545, DOI 10.1097/00006254-198709000-00003
[32]  
KAULHAUSEN H, 1981, AM J OBSTET GYNECOL, V10, P671
[33]   ATRIAL-NATRIURETIC-PEPTIDE AND PLASMA-VOLUME IN PREGNANCY-INDUCED HYPERTENSION [J].
LOWE, SA ;
ZAMMIT, VC ;
MITAR, D ;
MACDONALD, GJ ;
BROWN, MA .
AMERICAN JOURNAL OF HYPERTENSION, 1991, 4 (11) :897-903
[34]   FUNCTIONS OF THE RENIN-ANGIOTENSIN SYSTEM DURING DEVELOPMENT [J].
LUMBERS, ER .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1995, 22 (08) :499-505
[35]  
NICHOLSON EG, 1988, CLIN EXPER HYPER, V6, P435
[36]   DIMINISHED NUMBER OF RENIN-CONTAINING CELLS IN KIDNEY BIOPSY SAMPLES FROM HYPERTENSIVE WOMEN IMMEDIATELY POSTPARTUM - AN IMMUNOMORPHOLOGIC STUDY [J].
NOCHY, D ;
BARIETY, J ;
CAMILLERI, JP ;
BARRES, D ;
CORVOL, P ;
MENARD, J .
KIDNEY INTERNATIONAL, 1984, 26 (01) :85-87
[37]   EFFECT OF ACUTE AND CHRONIC LOSARTAN THERAPY ON ACTIVE AND INACTIVE RENIN AND ACTIVE RENIN GLYCOFORMS [J].
OPSAHL, JA ;
GOLDBERG, MR ;
KATZ, SA .
AMERICAN JOURNAL OF HYPERTENSION, 1995, 8 (11) :1090-1098
[38]   EVIDENCE FOR A DIRECT STIMULATORY EFFECT OF PROSTACYCLIN ON RENIN RELEASE IN MAN [J].
PATRONO, C ;
PUGLIESE, F ;
CIABATTONI, G ;
PATRIGNANI, P ;
MASERI, A ;
CHIERCHIA, S ;
PESKAR, BA ;
CINOTTI, GA ;
SIMONETTI, BM ;
PIERUCCI, A .
JOURNAL OF CLINICAL INVESTIGATION, 1982, 69 (01) :231-239
[39]  
PAWLAK MA, 1992, J HYPERTENS, V10, P813
[40]  
Protasoni G, 1995, J HYPERTENS, V13, P1753